Bill Text: HI SCR173 | 2018 | Regular Session | Introduced

---

Bill Title: Urging The United States Food And Drug Administration To Expedite The Approval Of New Nonprescription Sunscreen Active Ingredients For Use In The United States.

Spectrum: Partisan Bill (Democrat 7-0)

Status: (Introduced - Dead) 2018-03-16 - Referred to CPH. [SCR173 Detail]

Download: Hawaii-2018-SCR173-Introduced.html

---

THE SENATE	S.C.R. NO.	173
TWENTY-NINTH LEGISLATURE, 2018
STATE OF HAWAII

SENATE CONCURRENT

RESOLUTION

 

 

urging the united states food and drug ADMINISTRATION to expedite the approval of new nonprescription sunscreen active ingredients for use in the united states.

 

 

     WHEREAS, currently there is a limited number of approved nonprescription sunscreen active ingredients in the United States; and

 

     WHEREAS, there are pending Time and Extent Applications filed by the sunscreen industry that seek approval by the United States Food and Drug Administration of use of nonprescription sunscreen active ingredients that are and have been used globally; and

 

     WHEREAS, as of the date of introduction of this measure, the United States Food and Drug Administration has not approved any of the applications submitted for nonprescription sunscreen active ingredients, despite the demonstrated safe and effective global use of these ingredients; and

 

     WHEREAS, this delay in approval has hampered the ability of the sunscreen industry to innovate and bring alternative ingredients to the United States market; now, therefore,

 

     BE IT RESOLVED by the Senate of the Twenty-ninth Legislature of the State of Hawai‘i, Regular Session of 2018, the House of Representatives concurring, that the United States Food and Drug Administration is urged to expedite the approval of new nonprescription sunscreen active ingredients and to work collaboratively with all relevant stakeholders to achieve approval of ingredients that provide consumers with more access and choice in sunscreen products while providing the sunscreen industry with the ability to innovate; and

 

     BE IT FURTHER RESOLVED that certified copies of this Concurrent Resolution be transmitted to the United States Commissioner of Food and Drugs, Majority Leader of the United States Senate, Speaker of the United States House of Representatives, members of Hawai‘i's congressional delegation, and each of the presiding officers of the legislative bodies of each state of the United States of America.

 

 

 

	OFFERED BY:	_____________________________

Report Title: 

Sunscreen Ingredients; FDA Approval